According to the announcement of the draft of the 2024 restricted stock incentive plan released by Sunshine Guojian Pharmaceutical (688336.SH), the number of restricted stocks to be granted to incentive objects is 6.3315 million shares, accounting for 1.03% of the total equity of the company at the time of the announcement of the draft of this incentive plan. The grant price of the restricted stocks in this plan is 12.00 yuan per share. The total number of incentive objects to be awarded for the first time under this incentive plan is 92.